Omar Antila
Staff Product Manager at FreeWill | Angel Investor in Biotech, Healthtech, Fintech, Web3, and Nonprofit Tech
- Role
- Angel Squad Member at Hustle Fund
- Location
- Philadelphia, PA, US
- LinkedIn followers
- 500 followers
About Omar Antila
I thrive on the steep part of the learning curve. My career is defined by adaptability. Currently, I lead product initiatives at FreeWill, where I sit at the intersection of technology and social impact.I also serve on the board of REchai LLC, where I advise on technology strategy.As an Operator, I specialize in zero-to-one launches and scaling complex SaaS. My background spans product leadership, agile coaching, and QA, giving me a deep understanding of the messy reality of building early-stage companies.I\'m an active angel investor through Hustle Fund\'s Angel Squad. I mainly invest in Pre-Seed and Seed founders building \"painkiller\" solutions, must-have products in massive markets with 100x potential. I focus on sectors where I have a specific domain knowledge and advantage: Fintech & Nonprofit Tech: Leveraging my work at FreeWill to back tools that democratize access to financial systems.🧬 Biotech & Healthtech: Supporting innovations that extend and improve life (currently studying Biotech and Health Information Management). Blockchain: Backing infrastructure that creates true utility.I am a founder-friendly, low-friction investor. I leverage my 20-year tech network to support founders with tactical product advice and introductions. I write small strategic checks and aim to be a high-ROI partner on your cap table.
Experience
Angel Squad Member
Nov 2025 — Present · Philadelphia, PA, US
Thesis & Focus:I target Pre-Seed and Seed-stage companies with valuations that support a 100x return profile. My primary sectors are Fintech, Biotech, Healthtech, Nonprofit Tech, and Web3, areas where I possess a specific domain advantage.Evaluation Framework:I do not rely on gut feel. Every deal is scored on a rubric (Team, Product, Market, Execution, Fundraisability) to eliminate bias. I specifically look for:Market:$50B+ opportunity with a clear path to $100M ARR.Product:\"Painkillers\"(must-haves) over \"Vitamins\"(nice-to-haves).Team: Founders with earned secrets and high execution velocity.Portfolio Construction:I treat early-stage investing as a 10-year illiquid asset class. My strategy relies on broad diversification (small checks, high volume) to capture power-law returns. To win allocation, I position myself as a value-add partner, using my 20-year tech network to accelerate founder success.
Education
University of Helsinki
Associate of Science - AS, Biology, General
2001 — 2003
Harvard Extension School
Graduate Certificate in Biotechnology Management (in progress), Biotechnology
Skills
- Mobile Devices
- E-Learning
- Website Localization
- Software Quality Assurance
- Process Improvement
- Software Development
- Project Planning
- Saas
- Localization Testing
- Vendor Management
- Test Planning
- Project Management
- Technical Documentation
- Trados
- Strategy
- Agile Project Management
- Product Management
- Testing
- Translation
- Internationalization
- Software Project Management
- Sdlc
- Solution Architecture
- Jira
- Mobile Applications
- Android
- Business Process Improvement
- Quality Management
- Agile Methodologies
- Translation Management
- Management
- L10n
- Localization
- Globalization
- Quality Assurance
- Product Development
- Test Cases
- Program Management
- Pmp
- Leadership
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.